IDH2 and glioblastoma: When looking at WHO grade IV glioblastomas, the tumors within the IDH-mutant cluster are associated with longer survival than tumors within the IDH-wildtype cluster, again consistent with prior studies of glioblastoma and the new WHO classifications [4, 17, 23, 26, 30, 46].